Carlsmed Adds AI Veteran Tony Jarc as Chief Product and AI Officer

  • Tony Jarc, Ph.D., appointed Chief Product and AI Officer at Carlsmed effective October 1, 2026.
  • Jarc joins from Intuitive Surgical, where he built the global AI organization and pioneered clinical AI innovations.
  • Appointment follows recent executive team changes, including CFO and COO additions.
  • Carlsmed's proprietary technology platform targets lumbar and cervical spine fusion with enhanced CMS reimbursement.

Carlsmed's appointment of Tony Jarc underscores the growing importance of AI in personalized spine surgery. The move aligns with broader industry trends toward AI-driven medical innovations and comes as Carlsmed seeks to scale its technology platform. With enhanced CMS reimbursement for its aprevo® lumbar fusion procedures, the company is positioning itself for strategic growth in a competitive medical technology landscape.

AI Integration
How Tony Jarc's expertise will accelerate Carlsmed's AI-enabled surgical solutions.
Market Leadership
Whether Carlsmed can sustain its market leadership position with enhanced executive team.
Execution Risk
The pace at which Carlsmed can scale its technology platform and commercialize new products.